Anti-Human CD217 Recombinant Antibody

Name: Anti-Human CD217 Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1255

YR1255

科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab

DATASHEET MSDS

Product Description

Alias	科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab
Catalog Number	YR1255
Molecular Name	Brodalumab
Host	Mouse
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Brodalumab (trade name Siliq in the US and Kyntheum in Europe) is a human monoclonal antibody designed for the treatment of inflammatory diseases. In February 2017 it received US FDA approval to treat moderate to severe plaque psoriasis in people who have not improved with other treatments. Use is linked to an increased risk of suicide.
CAS Number	1174395-19-7
Application	WB, IF, IP, Neut, FuncS, ELISA, FCM
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD217[Homo sapiens]

Login